Get started
Author

Rebecca Giddings

Observed name: Giddings, Rebecca
ORCID: 0000-0003-3028-2742
Observed ORCID: 0000-0003-3028-2742
OpenAlex ID: A5079901498
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
2021 · Madhumita Shrotri, Maria Krutikov, et al. · The Lancet Infectious Diseases · 185
PDF
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
2021 · Maria Krutikov, Tom Palmer, et al. · The Lancet Healthy Longevity · 118
PDF
Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic review
2024 · Rebecca Giddings, Anabel Joseph, et al. · The Lancet Digital Health · 64
PDF
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England
2021 · Anna Jeffery-Smith, Thomas A J Rowland, et al. · The Lancet Healthy Longevity · 57
PDF
Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study
2022 · Madhumita Shrotri, Maria Krutikov, et al. · The Lancet Healthy Longevity · 35
PDF
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
2022 · Gokhan Tut, Tara Lancaster, et al. · The Lancet Healthy Longevity · 25
Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review
2022 · Fiammetta M. Bozzani, Fern Terris-Prestholt, et al. · PharmacoEconomics · 16
PDF
Vaccine Effectiveness of the First Dose of ChAdox1 nCOV-19 and BNT162b2 Against SARS-CoV-2 Infection in Residents of Long Term Care Facilities (VIVALDI Study)
2021 · Madhumita Shrotri, Maria Krutikov, et al. · SSRN Electronic Journal · 16
Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models
2023 · Rebecca Giddings, Pitchaya Indravudh, et al. · PharmacoEconomics · 14
PDF
Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021
2021 · Rebecca Giddings, Maria Krutikov, et al. · Eurosurveillance · 10
Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward
2023 · Sergio Torres-Rueda, Fern Terris-Prestholt, et al. · PharmacoEconomics · 8
PDF
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
2022 · Gokhan Tut, Tara Lancaster, et al. · Nature Aging · 8
PDF
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
2022 · Oliver Stirrup, Maria Krutikov, et al. · The Journal of Infectious Diseases · 8
PDF
Booster Vaccination Strongly Enhances SARS-CoV-2-Specific Antibody and Cellular Responses in Elderly Residents of Care Homes
2021 · Gokhan Tut, Tara Lancaster, et al. · SSRN Electronic Journal · 4
Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities
2021 · Gokhan Tut, Tara Lancaster, et al. · SSRN Electronic Journal · 1
Influence of prognostic model survival estimates on communicated prognosis and treatment recommendations in lung cancer: a randomised factorial vignette study
2026 · Rebecca Giddings · University College London
183 Quality of life changes following treatment in patients with NSCLC: a systematic review and meta-analysis
2026 · Rebecca Giddings, Sindhu Bhaarrati Naidu, et al. · Cancer Treatment and Research Communications
PDF
98 Hospitalisation Rates following Systemic Anti-Cancer Treatments for Patients with Non-Small Cell Lung Cancer
2025 · Pinkie Chambers, Ofran Almossawi, et al. · Lung Cancer
Works count: 19
Citation count: 569
H-index: 10
I10-index: 10
Year
Topic
Type